Use of Placebo in Clinical Trials of Psychotropic Medication.

This position paper has been substantially revised by the Canadian Psychiatric Association's Research Committee and approved for republication by the CPA's Board of Directors on March 31, 2017. The original position paper was developed by the Scientific and Research Council and approved by the Board of Directors on October 4, 1996.